The manufacturer was informed that on (b)(6) 2023 a patient was implanted with a perceval size xl valve due to stenosis of the native valve leaflets.There was concomitant cabg surgery performed (1 vessel).The patient was in sinus rhythm post-operatively but was put under temporary pacemaker as per hospital protocol.Corcym representative was informed on (b)(6) 2023 that the patient was unable to get off temporary pacing and was scheduled for a permanent pacemaker implant.As per additional iformation received, permanent pacemaker was implanted on (b)(6) 2023 with no complications.As per medical judgement received, it's possible that the patient sinus rhythm will recover, hence the patient will be monitored by the cardiologists accordingly.The site didn't identify any procedural factors that may have contributed to the event.The patient's medical history and relevant risk factors, including a history of conduction disorders, are unknown and no information was shared with the manufacturer on patient's medication.It was reported that after implant the valve showed good flow, no regurgitation and improved lower mean and peak pressure gradients.No device malfunction is reported by the surgeon.
|
Updated fields: a2, b2, b5, g3, h2, h6, h10.The manufacturing and material records for the perceval heart valve and stent, model #icv1211, s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by manufacture¿s quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1211) perceval heart valve at the time of manufacture and release.Since the device remains implanted in the patient, no further investigation can be performed.No device malfunction has been reported by the site though and there is no evidence that the device didn't meet the specifications.Conduction disorders are common in patients with aortic valve diseases.As a result, it is common for patients to receive permanent pacemaker implantation after aortic valve replacement.Risk factors include preexisting conducting disease and preoperative aortic regurgitation.This event is, therefore, a known, inherent risk of the procedure, and it is listed among the potential adverse events in the perceval ifu.
|